<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>miRNAs regulate gene expression at the post-transcriptional level by degradation of <z:chebi fb="2" ids="33699">mRNA</z:chebi> and translational repression </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have shown that miR-181a is dysregulated in several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>; however, the clinical significance of miR‑181a in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We addressed this question by using quantitative real-time PCR (qRT-PCR) to analyze miR-181a expression in 162 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>There was no significant difference in miR-181a expression in <z:mpath ids='MPATH_458'>normal</z:mpath> colon vs. <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue samples were categorized into a low and high expression group based on miR-181a expression </plain></SENT>
<SENT sid="5" pm="."><plain>Comparison of the clinicopathological factors and prognosis in these two groups showed that the high expression group had a significantly poorer prognosis than the low expression group (P=0.011) </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate analysis indicated that high miR-181a expression was an independent significant prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>However, there no correlation was observed between miR-181a expression and clinicopathological parameters </plain></SENT>
<SENT sid="8" pm="."><plain>In vitro analysis revealed that the overexpression of miR-181a repressed the expression of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor, phosphatase and tensin homolog (PTEN) located on chromosome 10, at the <z:chebi fb="2" ids="33699">mRNA</z:chebi> level </plain></SENT>
<SENT sid="9" pm="."><plain>These data suggest that miR-181a may be a new independent prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>